SEC Filing · 25-NSE
Virpax Pharmaceuticals, Inc.
VRPXOTCEQUITYCurrent
SEC Filing
Company context
We are a preclinical-stage pharmaceutical company focused on developing novel and proprietary drug delivery systems across various pain indications in order to enhance compliance and optimize each product candidate in our pipeline. Our drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (“CNS”) disorders to enhance patients’ quality of life.
Current securities
Historical securities (1)
As-filed source
As filedOpen full document ↗